文献速递生殖医学

全外显子组测序识别非综合征型原发性卵巢功能不全患者的新突变

New mutations in non-syndromic primary ovarian insufficiency patients identified via whole-exome sequencing.
PubMed 文献 · Hum Reprod · 2017-01-01

本研究对69例非综合征型原发性卵巢功能不全(POI)女性进行回顾性队列全外显子组测序,在420个候选基因中分析非同义变异,33例(48%)检出55个可能相关编码变异,42%患者存在至少两个不同基因的突变,提示POI的多基因性质。

要点

  • 全外显子组测序在69例POI患者中33例(48%)检出55个候选基因编码变异。
  • 42%患者携带至少两个不同基因的突变,支持POI的多基因性质。
  • BMPR1B和GREM1突变经片段分子轨道分析提示可能导致蛋白质去稳定化。

核心结论

  • 全外显子组测序是研究POI遗传病因的有效工具,所识别的部分新突变可能导致蛋白质去稳定化,可能参与疾病病因。

研究设计与样本

  • 回顾性队列研究,纳入69例非综合征型原发性卵巢功能不全女性。
  • 对420个选定POI候选基因中的非同义序列变异进行全外显子组测序及创新生物信息学分析。
  • 采用片段分子轨道分析对BMPR1B和GREM1突变进行建模。

主要发现

  • 69例患者中33例(48%)检出49个基因中的55个编码变异,这些基因可能与此病相关。
  • 所涉及基因参与卵巢减数分裂、卵泡发育、颗粒细胞分化/增殖及排卵等关键生物学过程。
  • 42%的患者在不同基因中存在至少两个突变,支持POI的多基因性质。

局限性

  • 本研究未分析调控区域,这些区域可能携带与POI相关的其他变异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Is it possible to identify new mutations potentially associated with non-syndromic primary ovarian insufficiency (POI) via whole-exome sequencing (WES)? SUMMARY ANSWER: WES is an efficient tool to study genetic causes of POI as we have identified new mutations, some of which lead to protein destablization potentially contributing to the disease etiology. WHAT IS KNOWN ALREADY: POI is a frequently occurring complex pathology leading to infertility. Mutations in only few candidate genes, mainly identified by Sanger sequencing, have been definitively related to the pathogenesis of the disease. STUDY DESIGN, SIZE, DURATION: This is a retrospective cohort study performed on 69 women affected by POI. PARTICIPANTS/MATERIALS, SETTING, METHODS: WES and an innovative bioinformatics analysis were used on non-synonymous sequence variants in a subset of 420 selected POI candidate genes. Mutations in BMPR1B and GREM1 were modeled by using fragment molecular orbital analysis. MAIN RESULTS AND THE ROLE OF CHANCE: Fifty-five coding variants in 49 genes potentially related to POI were identified in 33 out of 69 patients (48%). These genes participate in key biological processes in the ovary, such as meiosis, follicular development, granulosa cell differentiation/proliferation and ovulation. The presence of at least two mutations in distinct genes in 42% of the patients argued in favor of a polygenic nature of POI. LIMITATIONS, REASONS FOR CAUTION: It is possible that regulatory regions, not analyzed in the present study, carry further variants related to POI. WIDER IMPLICATIONS OF THE FINDINGS: WES and the in silico analyses presented here represent an efficient approach for mapping variants associated with POI etiology. Sequence variants presented here represents potential future genetic biomarkers. STUDY FUNDING/COMPETING INTEREST(S): This study was supported by the Universidad del Rosario and Colciencias (Grants CS/CIGGUR-ABN062-2016 and 672-2014). Colciencias supported Liliana Catherine Patiño´s work (Fellowship: 617, 2013). The authors declare no conflict of interest.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Patiño LC, Beau I, Carlosama C, et al. New mutations in non-syndromic primary ovarian insufficiency patients identified via whole-exome sequencing. Hum Reprod. 2017. PMID: 28505269. doi:10.1093/humrep/dex089

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。